Cyclerion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Invus Public Equities, L.P.(5.7%),Invus Public Equities Advisors, LLC(5.7%), etc.
Cyclerion Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Invus Public Equities, L.P.(5.7%),Invus Public Equities Advisors, LLC(5.7%)等
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。